{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-045937","form_type":"8-K","ticker":"ANIP","cik":"0001023024","company_name":"ANI PHARMACEUTICALS INC","filed_at":"2025-05-08T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.170614+00:00","generated_at":"2026-05-22T02:56:41.686657+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"ANI Pharmaceuticals supplements proxy statement on stock plan share reserve","bullets":["As of March 24, 2025, total stock options outstanding: 571,880 (weighted avg exercise price $46.28, remaining term 3.68 yrs).","Performance/restricted stock awards: 1,866,153 shares; shares available for future grant: 1,177,800.","Inducement grants (non-shareholder approved) comprise 184,989 options at avg exercise price $29.63, term 5.57 yrs.","Company seeks approval of Amended and Restated 2022 Stock Incentive Plan; no changes to other proposals or meeting date."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-045937","json":"https://secwatch.observer/filing/0001104659-25-045937.json","markdown":"https://secwatch.observer/filing/0001104659-25-045937.md","text":"https://secwatch.observer/filing/0001104659-25-045937.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1023024/000110465925045937/0001104659-25-045937-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1023024/000110465925045937/tm2514446d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T02:56:41.686657+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}